DASI Simulations Secures $5 Million in Third Funding Round and Expands Commercial Partnerships
DASI Simulations has successfully closed its third funding round, raising $5 million to accelerate its AI-driven predictive modeling products for structural heart care. Alongside this financial milestone, the company has finalized 11 commercial agreements with healthcare centers across multiple U.S. states including Arizona, California, Georgia, Massachusetts, South Carolina, Pennsylvania, and New Jersey.
This surge in demand has prompted DASI to expand its sales team, engineering talent, and patent portfolio. The company also implemented a 24/7 customer service system to support its growing user base and improve case processing turnaround times.
Commercial Growth and Market Penetration
Founder and CEO Teri Sirset highlights the progress made in the first quarter: “We signed agreements with a leading structural heart center, and we have another 20 contracts in the final stages of negotiation with over 50 more prospects at earlier stages.” This momentum reflects strong market validation for DASI’s AI-powered tools in structural heart interventions.
Product Development Advances
CTO Lakshmi (Prasad) Dasi reports key developments in the product pipeline, including a newly granted patent allowance for AI-based prediction of thrombosis following structural heart procedures. Additionally, a beta version of the post-TAVR gradient prediction tool has been released, supported by an article accepted for publication in the peer-reviewed Journal of Thoracic and Cardiovascular Surgery.
Automation improvements have been made to the case processing pipeline, speeding up results delivery. The introduction of an industry-standard ticketing system now offers round-the-clock customer support to clinical partners.
Strong Validation from Clinical Partners
Feedback from partner hospitals continues to be positive, especially regarding reimbursement success. One large center reported a reimbursement rate exceeding 98% using DASI’s HCPCS code.
Dr. Thomas Waggoner, Director of the Structural Heart Program at Tucson Medical Center, emphasizes the practical value: “Why wouldn’t you use DASI Simulations in every case—especially bicuspid valves, LVOT, calcium, and lifetime management? It’s easy to argue for its use in nearly every case.”
Industry Presence and Recognition
- DASI teams participated in CRT 2025, contributing to three scientific panel discussions.
- Their technology was featured in live cases at Stanford Medical Center and Tucson Medical Center during major cardiovascular intervention summits.
- Named a Best Place to Work in 2025 by Purpose Jobs.
- Featured presentations on AI-assisted TAVR at Miami Valves and medical AI sessions at the Controversies & Advances in the Treatment of Cardiovascular Disease conference.
DASI Simulations continues to support structural heart care with AI tools that improve predictive accuracy and clinical workflow efficiency. For product development professionals interested in AI applications in healthcare, this company demonstrates how targeted innovation can scale effectively in a highly regulated clinical environment.
Your membership also unlocks:
